HIST1H3A (Ab-36) Antibody

Shipped with Ice Packs
In Stock

Description

HIST1H3A and H3K36 Modifications

HIST1H3A (Histone Cluster 1 H3A) encodes histone H3.1, a core component of nucleosomes. Lysine 36 methylation (mono-, di-, or tri-methylation) and acetylation regulate transcriptional elongation, DNA repair, and heterochromatin formation . H3K36me3 is linked to active transcription and heterochromatin association in specific contexts , while acetylated H3K36 (H3K36ac) correlates with transcriptional activation .

Key Antibodies Targeting H3K36 Modifications

Commercial antibodies against H3K36 PTMs include:

TargetProduct NameSupplierApplicationsCitations
H3K36me3ab9050AbcamWB, ICC/IF, ChIP>975 publications
H3K36me1ab9048AbcamWB, ICC/IF112 publications
H3K36me229202-1-APProteintechWB, ELISA1 publication
H3K36acab272159AbcamDot blot, WB, IFN/A
Tri-methyl-HIST1H3A (K36)Tri-methyl-HIST1H3A (K36)CUSABIOUnspecifiedN/A

Specificity and Performance

  • ab9050 (H3K36me3):

    • Validated in HeLa cells via immunofluorescence (IF) and western blot (WB) at 1 µg/mL, showing nuclear localization .

    • No cross-reactivity with unmodified H3K36 or H3K37me3 peptides .

    • Observed band size: 17 kDa (vs. predicted 15 kDa) .

  • ab9048 (H3K36me1):

    • Specific to mono-methylated K36, with blocking confirmed using H3K36me1 peptide .

    • Compatible with methanol- or paraformaldehyde-fixed cells .

  • 29202-1-AP (H3K36me2):

    • Detects di-methylated H3K36 in human, mouse, and rat samples at 1:1000–1:8000 dilution in WB .

Functional Insights

  • H3K36me3 in Heterochromatin:
    Enriched in pericentromeric heterochromatin in mouse embryonic stem cells, suggesting roles beyond active transcription .

  • H3K36ac:
    Detected in C. elegans lysates, indicating evolutionary conservation of acetylation at this site .

Comparative Analysis of Antibody Performance

Parameterab9050 (H3K36me3)ab9048 (H3K36me1)29202-1-AP (H3K36me2)
Host SpeciesRabbitRabbitRabbit
ClonalityPolyclonalPolyclonalPolyclonal
Cross-reactivityNone with K36me1/me2None with K36me2/me3Unreported
Storage-20°C long-term -20°C -20°C

Key Research Findings

  • H3K36me3 deposition occurs in transcriptionally silent heterochromatin domains, challenging its canonical association with active genes .

  • H3K36 methylation antibodies show no cross-reactivity with adjacent residues (e.g., K37) , critical for precise epigenetic mapping.

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Typically, we can ship your order within 1-3 business days of receipt. Delivery times may vary depending on the shipping method and destination. Please consult your local distributor for specific delivery timeframes.
Synonyms
H3 histone family member E pseudogene antibody; H3 histone family; member A antibody; H3/A antibody; H31_HUMAN antibody; H3F3 antibody; H3FA antibody; Hist1h3a antibody; HIST1H3B antibody; HIST1H3C antibody; HIST1H3D antibody; HIST1H3E antibody; HIST1H3F antibody; HIST1H3G antibody; HIST1H3H antibody; HIST1H3I antibody; HIST1H3J antibody; HIST3H3 antibody; histone 1; H3a antibody; Histone cluster 1; H3a antibody; Histone H3 3 pseudogene antibody; Histone H3.1 antibody; Histone H3/a antibody; Histone H3/b antibody; Histone H3/c antibody; Histone H3/d antibody; Histone H3/f antibody; Histone H3/h antibody; Histone H3/i antibody; Histone H3/j antibody; Histone H3/k antibody; Histone H3/l antibody
Target Names
Uniprot No.

Target Background

Function
Histone H3A is a core component of nucleosomes. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to cellular machinery that requires DNA as a template. Histones therefore play a critical role in transcription regulation, DNA repair, DNA replication, and chromosomal stability. DNA accessibility is regulated through a complex set of post-translational modifications of histones, known as the histone code, and nucleosome remodeling.
Gene References Into Functions
  1. Research suggests that epigenetic regulation in cancer involves the induction of E3 ubiquitin ligase NEDD4-dependent histone H3 ubiquitination. PMID: 28300060
  2. Increased expression of H3K27me3 during a patient's clinical course may be helpful in determining whether tumors are heterochronous. PMID: 29482987
  3. JMJD5, a Jumonji C (JmjC) domain-containing protein, acts as a Cathepsin L-type protease that mediates histone H3 N-tail proteolytic cleavage under stress conditions causing a DNA damage response. PMID: 28982940
  4. Findings indicate that the Ki-67 antigen proliferative index has significant limitations, and phosphohistone H3 (PHH3) is an alternative proliferative marker. PMID: 29040195
  5. These results identify cytokine-induced histone 3 lysine 27 trimethylation as a mechanism that stabilizes gene silencing in macrophages. PMID: 27653678
  6. This data suggests that, in the early developing human brain, HIST1H3B comprises the largest proportion of H3.1 transcripts among H3.1 isoforms. PMID: 27251074
  7. This series of 47 diffuse midline gliomas revealed that histone H3-K27M mutation was mutually exclusive with IDH1-R132H mutation and EGFR amplification, rarely co-occurred with BRAF-V600E mutation, and was commonly associated with p53 overexpression, ATRX loss, and monosomy 10. Among these K27M+ diffuse midline gliomas. PMID: 26517431
  8. Research demonstrates that histone chaperone HIRA co-localizes with viral genomes, binds to incoming viral DNA, and deposits histone H3.3 onto it. PMID: 28981850
  9. These experiments showed that PHF13 binds specifically to DNA and to two types of histone H3 methyl tags (lysine 4-tri-methyl or lysine 4-di-methyl), where it functions as a transcriptional co-regulator. PMID: 27223324
  10. Hemi-methylated CpGs DNA recognition activates UHRF1 ubiquitylation towards multiple lysines on the H3 tail adjacent to the UHRF1 histone-binding site. PMID: 27595565
  11. For the first time, we describe the MR imaging features of pediatric diffuse midline gliomas with histone H3 K27M mutation. PMID: 28183840
  12. Approximately 30% of pediatric high-grade gliomas (pedHGG), including GBM and DIPG, harbor a lysine 27 mutation (K27M) in histone 3.3 (H3.3), which is correlated with poor outcome and was shown to influence EZH2 function. PMID: 27135271
  13. H3F3A K27M mutation in adult cerebellar HGG is not uncommon. PMID: 28547652
  14. Data indicate that lysyl oxidase-like 2 (LOXL2) is a histone modifier enzyme that removes trimethylated lysine 4 (K4) in histone H3 (H3K4me3) through an amino-oxidase reaction. PMID: 27735137
  15. Histone H3 lysine 9 (H3K9) acetylation was most prevalent when the Dbf4 transcription level was highest, whereas the H3K9me3 level was greatest during and just after replication. PMID: 27341472
  16. SPOP-containing complex regulates SETD2 stability and H3K36me3-coupled alternative splicing. PMID: 27614073
  17. This data suggests that binding of the helical tail of histone 3 (H3) with PHD ('plant homeodomain') fingers of BAZ2A or BAZ2B (bromodomain adjacent to zinc finger domain 2A or 2B) requires molecular recognition of secondary structure motifs within the H3 tail and could represent an additional layer of regulation in epigenetic processes. PMID: 28341809
  18. The results demonstrate a novel mechanism by which Kdm4d regulates DNA replication by reducing the H3K9me3 level to facilitate formation of the preinitiation complex. PMID: 27679476
  19. Histone H3 modifications caused by traffic-derived airborne particulate matter exposures in leukocytes. PMID: 27918982
  20. A key role of persistent histone H3 serine 10 or serine 28 phosphorylation in chemical carcinogenesis through regulating gene transcription of DNA damage response genes. PMID: 27996159
  21. hTERT promoter mutations are frequent in medulloblastoma and are associated with older patients, prone to recurrence and located in the right cerebellar hemisphere. Conversely, histone 3 mutations do not appear to be present in medulloblastoma. PMID: 27694758
  22. AS1eRNA-driven DNA looping and activating histone modifications promote the expression of DHRS4-AS1 to economically control the DHRS4 gene cluster. PMID: 26864944
  23. Data suggest that nuclear antigen Sp100C is a multifaceted histone H3 methylation and phosphorylation sensor. PMID: 27129259
  24. The authors propose that histone H3 threonine 118 phosphorylation via Aurora-A alters the chromatin structure during specific phases of mitosis to promote timely condensin I and cohesin disassociation, which is essential for effective chromosome segregation. PMID: 26878753
  25. Hemi-methylated DNA opens a closed conformation of UHRF1 to facilitate its H3 histone recognition. PMID: 27045799
  26. Functional importance of H3K9me3 in hypoxia, apoptosis, and repression of APAK. PMID: 25961932
  27. Taken together, the authors verified that histone H3 is a real substrate for GzmA in vivo in the Raji cells treated by staurosporin. PMID: 26032366
  28. We conclude that circulating H3 levels correlate with mortality in sepsis patients and inversely correlate with antithrombin levels and platelet counts. PMID: 26232351
  29. Data show that double mutations on the residues in the interface (L325A/D328A) decreases the histone H3 H3K4me2/3 demethylation activity of lysine (K)-specific demethylase 5B (KDM5B). PMID: 24952722
  30. Data indicate that minichromosome maintenance protein 2 (MCM2) binding is not required for incorporation of histone H3.1-H4 into chromatin but is important for the stability of H3.1-H4. PMID: 26167883
  31. Data suggest that histone H3 lysine methylation (H3K4me3) plays a crucial mechanistic role in leukemia stem cell (LSC) maintenance. PMID: 26190263
  32. PIP5K1A modulates ribosomal RNA gene silencing through its interaction with histone H3 lysine 9 trimethylation and heterochromatin protein HP1-alpha. PMID: 26157143
  33. Data indicate that lower-resolution mass spectrometry instruments can be utilized for histone post-translational modifications (PTMs) analysis. PMID: 25325711
  34. Data indicate that inhibition of lysine-specific demethylase 1 activity prevented IL-1beta-induced histone H3 lysine 9 (H3K9) demethylation at microsomal prostaglandin E synthase 1 (mPGES-1) promoter. PMID: 24886859
  35. The authors report that de novo CENP-A assembly and kinetochore formation on human centromeric alphoid DNA arrays are regulated by a histone H3K9 acetyl/methyl balance. PMID: 22473132

Show More

Hide All

Database Links

HGNC: 4766

OMIM: 137800

KEGG: hsa:8350

STRING: 9606.ENSP00000444823

UniGene: Hs.132854

Involvement In Disease
Glioma (GLM)
Protein Families
Histone H3 family
Subcellular Location
Nucleus. Chromosome.

Q&A

What is HIST1H3A and what cellular functions does it mediate?

HIST1H3A encodes histone H3, a core component of nucleosomes that wrap and compact DNA into chromatin. Histone H3 plays central roles in transcription regulation, DNA repair, DNA replication, and chromosomal stability . As one of several H3 variants (including H3.1, H3.2, and H3.3), HIST1H3A contributes to chromatin structure and function through post-translational modifications that regulate DNA accessibility .

Methodologically, when studying HIST1H3A functions, researchers should consider:

  • Different H3 variants have overlapping but distinct roles in chromatin regulation

  • Post-translational modifications create a complex "histone code" affecting chromatin states

  • Both canonical (replication-dependent) and variant (replication-independent) forms exhibit different biological properties in development and gene regulation

What are the key applications for anti-HIST1H3A antibodies in epigenetic research?

Anti-HIST1H3A antibodies are essential tools for investigating histone modifications and chromatin states. Common applications include:

ApplicationTypical DilutionSample TypesKey Considerations
Western Blotting (WB)1:500-1:2000Cell lysates, tissue extractsObserved molecular weight: ~18 kDa
Immunohistochemistry (IHC)1:50-1:500Fixed tissue sectionsRequires antigen retrieval with TE buffer pH 9.0 or citrate buffer pH 6.0
Immunocytochemistry (ICC/IF)VariableFixed cellsValidated for human samples
Chromatin Immunoprecipitation (ChIP)Application-specificCrosslinked chromatinCritical for mapping histone modifications genome-wide

Researchers should optimize antibody concentrations for each specific application and sample type, as the optimal dilution may vary depending on experimental conditions .

How do I distinguish between different histone H3 modifications at lysine 36 in experimental analyses?

Distinguishing between mono-, di-, and tri-methylation at H3K36 requires careful antibody selection and validation:

  • Antibody specificity: Select antibodies specifically validated for the precise methylation state (H3K36me1, H3K36me2, or H3K36me3)

  • Cross-reactivity testing: Validate antibody specificity against peptide arrays containing different modifications

  • Control experiments: Include appropriate positive and negative controls:

    • Use tissues/cells known to exhibit the modification of interest

    • Include genetic models where the modifying enzyme is depleted

    • Employ peptide competition assays to confirm specificity

For H3K36me3 specifically, researchers should be aware that this modification occurs in both actively transcribed regions and, surprisingly, in certain heterochromatic regions . This dual presence necessitates careful experimental design when interpreting H3K36me3 ChIP-seq or immunostaining data.

What sample preparation protocols are critical for successful western blotting with HIST1H3A antibodies?

Successful western blotting for histone H3 and its modifications requires careful attention to sample preparation:

  • Histone extraction: Use specialized acid extraction protocols (0.2N HCl or 0.4N H₂SO₄) to efficiently isolate histones from chromatin

  • Protein quantification: Bradford or BCA assays should be adjusted for highly basic proteins

  • Gel selection: Use 15-18% polyacrylamide gels to effectively resolve the low molecular weight (~18 kDa) histone proteins

  • Transfer conditions: Optimize for small proteins, typically using PVDF membranes and higher methanol concentrations

  • Blocking: Use 5% BSA rather than milk, as milk contains bioactive proteins that can introduce background

  • Antibody dilution: Titrate to determine optimal concentration, typically in the 1:500-1:2000 range for WB applications

When probing for specific histone modifications, it's advisable to first probe for total histone H3 on a duplicate blot or after stripping to normalize modification-specific signals to total H3 levels.

How can I effectively use H3K36me3 antibodies to study the dual role of this modification in both active transcription and heterochromatin formation?

H3K36me3 has a complex dual role in genome regulation, being associated with both actively transcribed genes and certain heterochromatic regions . To effectively study this duality:

  • Sequential ChIP (Re-ChIP): Perform ChIP with H3K36me3 antibodies followed by a second round with antibodies against:

    • Active marks (H3K4me3, RNA Pol II) to identify transcriptionally active regions

    • Repressive marks (H3K9me3, H4K20me3) to identify heterochromatic regions

  • Combined genomic approaches:

    • Integrate H3K36me3 ChIP-seq with RNA-seq data to correlate modification with transcription

    • Overlay with H3K9me3 or HP1 ChIP-seq data to identify regions where H3K36me3 co-occurs with heterochromatin marks

  • Cell-cycle analysis:

    • Synchronized cell populations can reveal cell-cycle-specific distributions of H3K36me3

    • This is particularly important as research has shown that "H3K36me3 is markedly enriched at the level of pericentromeric heterochromatin in mouse embryonic stem cells and fibroblasts"

Research has demonstrated that "H3K36me3 deposition within large heterochromatin domains does not correlate with transcription events, suggesting the existence of an alternative pathway for the deposition of this histone modification" . This finding challenges the conventional view that H3K36me3 is exclusively a mark of active transcription.

What are the critical differences between canonical and variant histone H3 forms, and how do antibodies distinguish between them?

Canonical (H3.1/H3.2) and variant (H3.3) histone H3 forms have distinct biological roles and chromatin deposition patterns:

FeatureCanonical H3 (H3.1/H3.2)Variant H3.3
ExpressionReplication-dependentReplication-independent
DepositionDuring S phaseThroughout cell cycle
Genomic enrichmentBroadly distributedEnriched at active genes and regulatory elements
Role in gene silencingMajor role in establishing H3K27me3 domainsImportant at specific subsets of genes
Effect of K36R mutationDisrupts H3K27me3 levels broadlyLess extensive effects on H3K27me3

Research in Drosophila has shown that "K36R H3.2 mutation disrupts H3K27me3 levels broadly throughout silenced domains, whereas these regions are mostly unaffected in K36R H3.3 animals" . This indicates differential roles for these variants in maintaining repressive chromatin states.

When selecting antibodies:

  • Carefully review the epitope information to determine if the antibody can distinguish between variants

  • Most general H3 antibodies recognize all variants due to high sequence similarity

  • For variant-specific detection, select antibodies raised against unique sequence regions or C-terminal differences

  • Consider genetic approaches (tagged variants) for unambiguous discrimination

What strategies can resolve inconsistent or weak signals when using HIST1H3A (Ab-36) antibodies in immunofluorescence applications?

When facing weak or inconsistent signals in immunofluorescence experiments with histone H3 antibodies:

  • Fixation optimization:

    • Test multiple fixation methods (4% PFA, methanol, or combination protocols)

    • Duration of fixation can significantly impact epitope accessibility

  • Antigen retrieval:

    • For tissue sections, heat-induced epitope retrieval using TE buffer pH 9.0 is recommended

    • Alternative methods include citrate buffer pH 6.0

    • Optimization of retrieval time and temperature is critical

  • Permeabilization:

    • Histone epitopes require thorough permeabilization (0.5% Triton X-100 for 15-30 minutes)

    • Consider detergent concentration and duration based on cell type

  • Blocking improvements:

    • Use 5% BSA or 10% normal serum from the secondary antibody host species

    • Include 0.1-0.3% Triton X-100 in blocking solution

    • Consider longer blocking times (2+ hours at room temperature)

  • Signal amplification:

    • Tyramide signal amplification systems can enhance weak signals

    • Longer primary antibody incubation (overnight at 4°C)

    • Higher antibody concentrations, particularly for detecting modifications with low abundance

Researchers should note that detecting specific modifications like H3K36me3 may require more extensive optimization than detecting total histone H3.

How do I analyze apparently conflicting ChIP-seq data when H3K36me3 is detected in both active genes and heterochromatic regions?

Resolving apparent conflicts in H3K36me3 distribution requires sophisticated analytical approaches:

  • Contextual analysis:

    • Examine co-occurring modifications at H3K36me3-enriched regions

    • Active regions typically show H3K4me3, H3K27ac, and RNA Pol II co-enrichment

    • Heterochromatic regions show H3K9me3, H4K20me3, and potentially HP1 co-enrichment

  • Differential binding analysis:

    • Use DiffBind or similar tools to identify quantitative differences in H3K36me3 enrichment

    • Compare peak shapes and breadth between euchromatic and heterochromatic regions

  • Integrative genomics:

    • Correlate with DNA methylation data (heterochromatic regions typically show higher methylation)

    • Integrate with chromatin accessibility data (ATAC-seq, DNase-seq)

    • Correlate with RNA-seq to distinguish transcriptionally active from silent regions

  • Advanced visualization:

    • Use metaplot analyses centered on transcription start sites (TSS) and transcription end sites (TES)

    • Generate heatmaps clustering regions based on multiple histone marks

    • Consider chromosome-specific analyses, as "H3K36me3 is markedly enriched at pericentromeric heterochromatin"

When analyzing such data, remember that "H3K36me3 deposition within large heterochromatin domains does not correlate with transcription events, suggesting the existence of an alternative pathway for the deposition of this histone modification" . This indicates distinct mechanisms may be responsible for H3K36me3 deposition in different genomic contexts.

How can HIST1H3A antibodies be effectively used to investigate the relationship between histone modifications and developmental gene regulation?

Investigating developmental roles of histone H3 modifications requires specialized approaches:

  • Developmental time course experiments:

    • ChIP-seq or CUT&RUN across developmental stages

    • Compare embryonic stem cells, progenitor populations, and terminally differentiated cells

    • Correlate changes in histone modifications with developmental gene expression programs

  • Cell type-specific profiling:

    • FACS-based isolation of specific cell populations followed by histone profiling

    • Single-cell approaches for heterogeneous tissues

    • CUT&TAG in specific tissues using cell type-specific promoters

  • Genetic manipulation strategies:

    • Study consequences of K36R mutations in either H3.2 or H3.3

    • Research shows different developmental outcomes when K36 is mutated in canonical versus variant H3

    • "Combined (K36R H3.2 K36R H3.3) mutants display widespread Hox gene misexpression and fail to develop past the first larval stage"

  • Focus on polycomb-regulated genes:

    • H3K36 methylation status significantly impacts polycomb silencing

    • "H3.2 and H3.3 K36 residues collaborate to repress Hox genes using different mechanisms"

    • The relationship between H3K36me3 and H3K27me3 appears context-dependent and developmental stage-specific

These approaches can reveal how different H3 variants and their modifications coordinate developmental gene regulation programs.

What methodological considerations are important when studying the interplay between H3K36me3 and other epigenetic modifications?

The interplay between H3K36me3 and other histone modifications requires sophisticated experimental approaches:

  • Sequential ChIP protocols:

    • Optimize crosslinking and sonication conditions for efficient immunoprecipitation of dual-modified chromatin

    • Use spike-in controls to ensure quantitative recovery

    • Consider alternative approaches like CUT&RUN or CUT&TAG for improved sensitivity

  • Mass spectrometry approaches:

    • Histone PTM quantitation by mass spectrometry can detect co-occurrence on the same histone tail

    • Middle-down or top-down proteomics approaches preserve combinatorial modification information

    • Targeted approaches can focus on specific histone peptides containing K36

  • Enzyme inhibitor studies:

    • Use specific inhibitors of methyltransferases or demethylases

    • Monitor consequences on other modifications

    • Include appropriate time courses to distinguish direct from indirect effects

  • Domain-focused analysis:

    • For facultative heterochromatin studies, focus on imprinted regions where "the silenced, maternally contributed 3-Mb imprinted region" contains H3K36me3 despite silencing

    • For constitutive heterochromatin, examine "pericentromeric heterochromatin in mouse embryonic stem cells and fibroblasts" where H3K36me3 is enriched

  • Integrative analysis frameworks:

    • Use computational approaches that identify combinatorial histone modification patterns

    • Hierarchical clustering of modification co-occurrence

    • Machine learning approaches to identify predictive relationships between modifications

Understanding these relationships is critical as research has shown unexpected associations, such as H3K36me3 being present in heterochromatic regions traditionally associated with repressive marks like H3K9me3 and H4K20me3 .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.